Τίτλος:
Prevalence of diabetes and pre-diabetes in Greece. Results of the First National Survey of Morbidity and Risk Factors (EMENO) study
Γλώσσες Τεκμηρίου:
Αγγλικά
Περίληψη:
Aims: To report the results of the first national Health Examination Survey (HES) on the prevalence of diabetes, its pharmacologic treatment and level of control, as well as pre-diabetes in Greece. Methods: Data were derived from the National Survey of Morbidity and Risk Factors (EMENO), in a randomly selected, representative sample of the adult Greek population. Sampling weights were applied to adjust for study design and post-stratification weights to match sample age/sex distribution to the population. Non-response was adjusted by inverse probability weighting. Weighted prevalence estimates are provided. Results: A total of 4393 persons with HbA1c and/or fasting plasma glucose measurements were included. Total diabetes prevalence was 11.9% (95% CI: 10.9–12.9), known diabetes 10.4% (9.5–11.4), and unknown 1.5% (1.1–1.9), with considerable increase in older age groups and no difference between genders. Pre-diabetes prevalence was 12.4% (11.4–13.6). The majority of persons with known diabetes were receiving metformin. Of those with known diabetes (and measured HbA1c), 70.9% were well controlled (HbA1c <7.0%). Conclusions: This first representative national HES showed high prevalence of diabetes in Greece, with low prevalence of unknown diabetes. Pre-diabetes prevalence is also substantial. These results will hopefully enable national authorities develop tailored and efficient strategies for disease prevention and management. © 2020
Συγγραφείς:
Makrilakis, K.
Kalpourtzi, N.
Ioannidis, I.
Iraklianou, S.
Raptis, A.
Sotiropoulos, A.
Gavana, M.
Vantarakis, A.
Kantzanou, M.
Hadjichristodoulou, C.
Chlouverakis, G.
Trypsianis, G.
Voulgari, P.V.
Alamanos, Y.
Touloumi, G.
Liatis, S.
Περιοδικό:
Diabetes Research and Clinical Practice
Εκδότης:
Elsevier Ireland Ltd
Λέξεις-κλειδιά:
dipeptidyl peptidase IV inhibitor; glucose; hemoglobin A1c; insulin; metformin; sulfonylurea, adult; age distribution; aged; Article; body weight; controlled study; diabetes mellitus; female; geriatrics; glucose blood level; Greece; Greek (people); groups by age; health service; human; impaired glucose tolerance; major clinical study; male; prevalence; risk factor; sex ratio; wellbeing; adolescent; cross-sectional study; diabetes mellitus; impaired glucose tolerance; middle aged; morbidity; mortality; prevalence; questionnaire; young adult, Adolescent; Adult; Aged; Cross-Sectional Studies; Diabetes Mellitus; Female; Greece; Humans; Male; Middle Aged; Morbidity; Prediabetic State; Prevalence; Risk Factors; Surveys and Questionnaires; Young Adult
DOI:
10.1016/j.diabres.2020.108646
